Scholars Central

Conference abstractPublished 5 Aug 2021

Role of metabolic derangements in disease development of Sepsis and Burn Injury

Authors: Masao Kaneki

Massachusetts General Hospital, Harvard Medical School, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Metabolic derangements, including insulin resistance, muscle wasting hyperlactatemia and mitochondrial dysfunction, are a major complication of critical illness (e.g., sepsis, burn injury) and negatively affect clinical outcomes of critically ill patients. However, the underlying mechanisms of critical illness-induced metabolic disturbances remain to be clarified. In addition, whether metabolic derangements have a pathogenic role in critical illness is not clear. We have shown that burn injury induces: (1) insulin resistance, as indicated by suppressed IRS-1 expression and impaired insulin-stimulated phosphorylation of the IRS1-Akt pathway along with basal hyperactivation of mTORC1; (2) the Warburg effect, as indicated by induction of HIF-1α and its downstream glycolytic genes, and increased lactate secretion; and (3) mitochondrial dysfunction/disintegrity in mouse muscle. Moreover, our recent data show that deficiency of myostatin (a myokine and a potent inducer of muscle atrophy) improves survival and bacterial clearance and mitigates organ damage and inflammation in septic mice (Fig. 1). These results suggest that muscle cachexic changes (e.g., alterations in myokines and metabolites secreted by skeletal muscle) may drive disease development in septic mice. Hyperlactatemia is a predictor of mortality of critically ill patients. Lactic acid can induce immunosuppressive phenotypes in macrophages and T-cells, while it can also prolong inflammatory response in immune cells. It is suggested that hyperlactatemia may contribute to the concomitant presence of immune suppression and persistent inflammation, a feature of sepsis and burn injury. Our data show that myostatin deficiency as well as HIF-1α knockout in skeletal muscle blocks sepsisinduced hyperlactatemia in mice. Together, these findings suggest that prevention of hyperlactatemia may be a contributor to the protective effects of myostatin deficiency in septic mice. Overall, these studies indicate that the myostatin pathway and the HIF-1α pathway in skeletal muscle are novel, potential molecular targets to improve clinical outcomes of septic patients and burn patients.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Endocrinology & Metabolic Syndrome.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalEndocrinology & Metabolic Syndrome
  • SubjectDiabetes & Endocrinology
  • BylineArticles whose byline prints “Masao Kaneki”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels